Position in AMRX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$12,210,025
+$3,860,674 QoQ
Shares Held
982,303
+48.2% QoQ
Ownership
0.308%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 85.78737925059782.ToString("F0")%
Shared 0.ToString("F0")%
None 14.212620749402168.ToString("F0")%
Common Shares in AMRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026JPMORGAN CHASE & CO holds $2,053,486,048 across 61 Drug Manufacturers - Specialty & Generic names. AMRX ranks #16 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
5,442,067 | $716,937,900 | |
| 2 | ZTS |
Zoetis Inc.
|
3,387,174 | $400,397,831 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
6,762,744 | $203,693,847 | |
| 4 | ALKS |
Alkermes plc.
|
4,101,789 | $145,039,257 | |
| 5 | HIMS |
Hims & Hers Health, Inc.
|
5,240,816 | $108,799,337 | |
| 6 | HLN |
Haleon plc
|
8,279,468 | $82,877,469 | |
| 7 | VTRS |
Viatris Inc
|
5,731,565 | $77,433,437 | |
| 8 | RDY |
Dr Reddys Laboratories Ltd
|
4,371,378 | $60,543,580 |
All Filings in AMRX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12,210,025 | 982,303 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $8,349,351 | 662,647 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $7,719,759 | 771,205 | Shares | Defined | 2025-11-26 | |
| 2025-06-30 | $10,778,839 | 1,332,366 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $9,148,360 | 1,091,690 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $9,622,577 | 1,214,972 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $10,791,820 | 1,297,094 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $3,298,987 | 519,526 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $2,558,063 | 422,123 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $1,129,268 | 186,041 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $2,476,122 | 586,759 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,650,841 | 532,530 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $438,317 | 315,337 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $611,013 | 307,042 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $745,300 | 368,961 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,190,594 | 374,401 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $1,515,314 | 363,385 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $1,736,498 | 362,526 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $2,000,758 | 374,674 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $2,062,514 | 402,835 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $2,854,205 | 424,102 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $2,228,660 | 487,672 | Shares | Defined | 2021-02-19 | |
| 2020-09-30 | $143,455 | 36,973 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $159,850 | 33,582 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $135,646 | 38,979 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||